We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
236 hedge funds and large institutions have $2.4B invested in Acadia Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 77 increasing their positions, 81 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
168% more call options, than puts
Call options by funds: $22M | Put options by funds: $8.23M
5% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 81
2.26% less ownership
Funds ownership: 92.42% → 90.16% (-2.3%)
3% less funds holding
Funds holding: 244 → 236 (-8)
19% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 37
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
33% less capital invested
Capital invested by funds: $3.61B → $2.4B (-$1.2B)
Holders
236
Holders Change
-8
Holders Change %
-3.28%
% of All Funds
4.13%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
30
Increased
77
Reduced
81
Closed
37
Calls
$22M
Puts
$8.23M
Net Calls
+$13.8M
Net Calls Change
-$17.3M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$33.9M |
| 2 |
D.E. Shaw & Co
New York
|
+$15.5M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$12.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$12.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.8M |
